ATE ATE

Antibe Therapeutics Stock Price

0.47
0.00 (0.0%)
0.47

Low
0.465

52 Week Range

High
0.83

Company Name Stock Ticker Symbol Market Type
Antibe Therapeutics Inc ATE Toronto Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.47 16:00:02
Open Price Low Price High Price Close Price Prev Close
0.47 0.47 0.47 0.47 0.47
Trades Volume Avg Volume 52 Week Range
2 10,034 - 0.465 - 0.83
Last Trade Time Type Quantity Stock Price Currency
10:05:33 10,000 $ 0.47 CAD

Period:

Draw Mode:

Antibe Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.51M 43.15M 43.15M $ 2.73M $ 0.00 -0.50 -1.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
21.40k $ - - 0.00 -

more financials information »

Antibe Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.470.490.470.47853415,3130.000.0%
1 Month0.520.520.4650.482607620,250-0.05-9.62%
3 Months0.640.710.4650.550973519,325-0.17-26.56%
6 Months0.680.750.4650.595301722,211-0.21-30.88%
1 Year0.730.830.4650.665513435,436-0.26-35.62%
3 Years0.4157.520.3752.22140,6770.05513.25%
5 Years0.4157.520.3752.22140,6770.05513.25%

Antibe Therapeutics Description

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions.